A DNA methylation profile of long non-coding RNAs can predict OS in prostate cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Xu J, Lan Y, Yu F, et al. Transcriptome analysis reveals a long non-coding RNA signature to improve biochemical recurrence prediction in prostate cancer. Oncotarget. 2018;9(38):24936–24949.
   PubMedGoogle Scholar
• Pistore C, Giannoni E, Colangelo T, et al. DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells. Oncogene. 2017;36(40):5551–5566.
   PubMed Web of Science ®Google Scholar
• Luo H, Zhao Q, Wei W, et al. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer. Sci Transl Med. 2020;12(524).
   Web of Science ®Google Scholar
• Lemos AEG, Matos ADR, Ferreira LB, et al. The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer. Oncotarget. 2019;10(61):6589–6603.
   PubMedGoogle Scholar
• Merry CR, Forrest ME, Sabers JN, et al. DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer. Hum Mol Genet. 2015;24(21):6240–6253.
   PubMed Web of Science ®Google Scholar
• Pang X, Zhao Y, Wang J, et al. Competing endogenous RNA and coexpression network analysis for identification of potential biomarkers and therapeutics in association with metastasis risk and progression of prostate cancer. Oxid Med Cell Longev. 2019;2019:8265958.
   PubMed Web of Science ®Google Scholar
• Tomczak K, Czerwinska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19(1A):A68–77.
   PubMedGoogle Scholar
• Morris TJ, Beck S. Analysis pipelines and packages for infinium humanmethylation450 beadchip (450k) data. Methods. 2015;72:3–8.
   PubMed Web of Science ®Google Scholar
• Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for the ENCODE project. Genome Res. 2012;22(9):1760–1774.
   PubMed Web of Science ®Google Scholar
• Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363–1369.
   PubMed Web of Science ®Google Scholar
• Yu P, Tong L, Song Y, et al. Systematic profiling of invasion-related gene signature predicts prognostic features of lung adenocarcinoma. J Cell Mol Med. 2021. DOI:10.1111/jcmm.16619
   Web of Science ®Google Scholar
• Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337–344.
   PubMed Web of Science ®Google Scholar
• Zhang J, Shi K, Huang W, et al. The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma. Cancer Cell Int. 2019;19(1):107.
   PubMedGoogle Scholar
• Huang DW, Sherman BT, Tan Q, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35(suppl_2):W169–75.
   PubMed Web of Science ®Google Scholar
• Hombach S, Kretz M. Non-coding RNAs: classification, biology and functioning. Adv Exp Med Biol. 2016;937:3–17.
   PubMed Web of Science ®Google Scholar
• O’Leary VB, Hain S, Maugg D, et al. Long non-coding RNA PARTICLE bridges histone and DNA methylation. Sci Rep. 2017;7(1):1790.
   PubMedGoogle Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Martini M, De Santis MC, Braccini L, et al. PI3K/AKT signaling pathway and cancer: an updated review. Ann Med. 2014;46(6):372–383.
   PubMed Web of Science ®Google Scholar
• Zhi H, Li Y, Wang L. Profiling DNA methylation patterns of non-coding RNAs (ncRNAs) in human disease. Adv Exp Med Biol. 2018;1094:49–64.
   PubMed Web of Science ®Google Scholar
• Komolov KE, Benovic JL. G protein-coupled receptor kinases: past, present and future. Cell Signal. 2018;41:17–24.
   PubMed Web of Science ®Google Scholar
• Ravnskjaer K, Madiraju A, Montminy M. Role of the cAMP pathway in glucose and lipid metabolism. Handb Exp Pharmacol. 2016;233:29–49.
   PubMedGoogle Scholar
• Lee JM, Davis FM, Roberts-Thomson SJ, et al. Ion channels and transporters in cancer. 4. Remodeling of Ca 2+ signaling in tumorigenesis: role of Ca 2+ transport. Am J Physiol Cell Physiol. 2011;301(5):C969–76.
   PubMed Web of Science ®Google Scholar
• Tradonsky A, Rubin T, Beck R, et al. A search for reliable molecular markers of prognosis in prostate cancer: a study of 240 cases. Am J Clin Pathol. 2012;137(6):918–930.
   PubMed Web of Science ®Google Scholar
• Cai C, Wang W, Tu Z. Aberrantly DNA methylated-differentially expressed genes and pathways in hepatocellular carcinoma. J Cancer. 2019;10(2):355–366.
   PubMed Web of Science ®Google Scholar
• Yang Y, Xun N, Wu JG. Long non-coding RNA FGF14-AS2 represses proliferation, migration, invasion, and induces apoptosis in breast cancer by sponging miR-205-5p. Eur Rev Med Pharmacol Sci. 2019;23(16):6971–6982.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhang X, Rong L, et al. Integrative analysis of the gastric cancer long non-coding RNA-associated competing endogenous RNA network. Oncol Lett. 2021;21(6):456.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Taheri M. Maternally expressed gene 3 (MEG3): a tumor suppressor long non coding RNA. Biomed Pharmacother. 2019;118:109129.
   PubMed Web of Science ®Google Scholar
• Zhou DD, Liu XF, Lu CW, et al. Long non-coding RNA PVT1: emerging biomarker in digestive system cancer. In: Cell Prolif. 2017;.50(6).
   Google Scholar